Celgene Corporation (CELG)

NASDAQ
108.24
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    107.27 - 108.59
  • 52 wk Range:
    0.00 - 0.00

CELG Overview

Prev. Close
108.13
Day's Range
107.27-108.59
Revenue
16.98B
Open
108.01
52 wk Range
0-0
EPS
8.02
Volume
0
Market Cap
77.04B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
6,952,666
P/E Ratio
13.49
Beta
1.42
1-Year Change
0%
Shares Outstanding
711,714,480
Next Earnings Date
-
What is your sentiment on Celgene?
or
Market is currently closed. Voting is open during market hours.

Celgene Corporation News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Celgene Corporation Analysis

Celgene Corporation Company Profile

Celgene Corporation Company Profile

Employees
8852

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. The company offers ABRAXANE, a paclitaxel powder for injectable suspension nanoparticle; IDHIFA that are enasidenib tablets; INREBIC, which are fedratinib capsules; ISTODAX, a lyophilized powder for injection; ONUREG that are azacitidine tablets; POMALYST, pomalidomide capsules; REBLOZYL, an injection for luspatercept; REVLIMID that are lenalidomide capsules; THALOMID, which are thalidomide capsules; VIDAZA, an injection of azacytidine; and ZEPOSIA that are ozanimod capsules. It provides pharmaceuticals in the areas of oncology, hematology, immunoscience, cardiovascular, and fibrosis. The company was incorporated in 1986 and is headquartered in Summit, New Jersey. Celgene Corporation is a subsidiary of Bristol-Myers Squibb Company.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralBuyStrong Buy
Technical IndicatorsStrong BuyStrong BuySellNeutralStrong Buy
SummaryStrong BuyStrong BuyNeutralNeutralStrong Buy
  • Oh Yeah, baby!
    0
    • Anyone know what they plan to do with the capital from divestitures ahead of merger?  Special dividend or spin off would be nice :D
      1
      • True
        0
    • What happens to CELG call options (CELG JAN 15, 2021 100.00) when the buy out occurs?. . . Thanks in advance
      0
      • https://www.investopedia.com/ask/answers/06/optionsbuyout.asp
        0
      • I just realized that link doesn't answer much of anything. Very good question though
        0
    • 94.34 today
      0
      • 94.38 +7.94% ... awesome!
        1
        • Shows essence of Value Invest Trading indeed!
          1
      • what an opportunity to buy....amazing
        0
        • sure is behaving oddly
          0
          • Is it just me but ever since the hemp business is starting to get legal medical companies are starting to panic.
            0
            • Certainly some will be worried. Not sure the immunology biotechs have much to worry about. Opioids will but right now it looks like they have been troubles ahead!
              0
          • this will rip
            0
            • rip indeed
              0
          • what is the target price
            0